Solna, Sweden · Founded 2006 · Privately Held (backing)
Developer of pharmaceutical drugs designed to treat cognitive neurological disorders. Umecrine Cognition is based in Solna, Sweden and was founded in 2006. Its last reported valuation was $71.5 million in Jul 2021. It has raised $28.1 million.
Last reported valuation
$71.5M
Oct 2026
Priced at
—
Total raised
$28.1M
Last round
—
Cap table — not yet on record
Umecrine Cognition's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Umecrine Cognition with a free account
·Watch Umecrine Cognition: the Monday email on marks, rounds and moves
